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SUMMARY
Specific cutaneous involvement in Hodgkin Lymphoma is rare and has not been 
reported in the younger paediatric age group. We report a case of a ten year old girl who 
presented with specific cutaneous involvement, confirmed using immunohistochemical 
stains. Treatment with combination chemotherapy resulted in rapid disappearance of 
the lesions and contrary to the generally poor prognosis associated with most other 
such reported cases in adults, she has clinically remained disease free two and a half 
years post treatment. Obtaining an accurate pathological diagnosis is essential to ensure 
appropriate treatment even in resource limited settings as illustrated by this case. 
INTRODUCTION
Specific cutaneous involvement in Hodgkin 
Lymphoma is rare and may be due to retrograde 
lymphatic spread, direct extension from lymph 
nodes or haematogenous dissemination (1-4). Skin 
involvement is an indication of stage IV disease and 
is generally associated with a poor prognosis (1,3,5,6). 
Its incidence has decreased and this is likely due to 
improved treatment of Hodgkin Lymphoma (1,7). 
There have been no reports of cutaneous Hodgkin 
Lymphoma in the younger paediatric population. 
We report a case of a ten year old girl who presented 
with specific cutaneous involvement of Hodgkin 
Lymphoma, confirmed by immunohistochemical 
stains, who responded well to chemotherapy and 
has remained disease free two and a half years post 
treatment completion. 
CASE REPORT
The patient was referred to Korle Bu Teaching hospital, 
in Accra, Ghana, at ten years of age with a six month 
history of fever, weight loss and a two month history 
of left sided neck swelling and skin rash. She had 
received two months anti-tuberculosis treatment 
at a District Hospital for possible extra-pulmonary 
tuberculosis. She appeared cachectic, weight 26.5Kg, 
febrile, pale and had generalised non-tender discrete 
firm cervical, axillary and inguinal lymphadenopathy. 
There were hyperpigmented firm to hard papules, 
nodules and plaques with areas of scaling of the left 
side of the neck, left haemithorax, inner aspect of left 
arm and left upper quadrant of abdomen (Fig.1).  The 
lesions were pruritic. She also had a swelling of the 
medial canthus of the left eye, hyperpigmented lips 
and violaceous plaques on her hard palate. There 
was haepatomegaly measuring 4cm below the right 
subcostal margin. The spleen was not palpable. The 
differential diagnosis included Kaposi's sarcoma, 




Investigations : These were limited due to resource 
constraints. HIV serology was negative. Full blood 
count revealed Haemoglobin 9.9g/dl,  white blood 
count 22.1 x 10^9/l (neutrophils 17.6 x 10^9/l), 
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platelets 92 x 10^9/l. Electrolytes, urea, creatinine, 
uric acid were normal. Bone marrow aspirate was 
not taken prior to starting chemotherapy due to 
logistic reasons but a specimen taken at week 
four prior to the second cycle of chemotherapy 
showed no evidence of malignant infiltration. 
Her chest Xray was normal. Abdomino-pelvic 
ultrasound scan revealed mild haepatomegaly 
and retroperitoneal lymphadenopathy. No CT/
MRI scans were done due to lack of funds and PET 
scans are not available locally. Skin biopsies showed 
normal to slightly hyperplastic epidermis overlying 
aggregates and diffuse infiltration of lymphocytes, 
histiocytes, neutrophils and eosinophils. There were 
mononuclear, binucleated and multilobed Reed-
Sternberg cells irregularly distributed. Occasional 
lacunar cells were seen and stromal fibrosis was 
evident. Lymphnode biopsy showed complete 
effacement of architecture by malignant lymphoma 
and presence of diffuse and nodular fibrosis. In the 
background of polymorphous infiltrate including 
neutrophils, eosinophils, lymphocytes and plasma 
cells were multinucleated, mononuclear lacunar Reed 
Sternberg cells (Figure 2). 
 
Figure 2 
Lymph node biopsy (H&E x40)
A tentative diagnosis of cutaneous involvement 
of Nodular Sclerosing Hodgkin Lymphoma 
was made. Specimens sent to South Africa and 
immunoperoxidase stains done showed: MUM 1 – 
definite nuclear staining in sub-population of tumour 
cells. ALK 1 – negative. CD45 – negative in skin and 
lymph node biopsy. EMA – difficult to interpret. 
CD30 – strong membrane and/or paranuclear staining 
observed in tumour cells. CD15 – no definite positive 
staining tumour cells. CD20 – negative in tumour 
cells. CD3 – negative in tumour cells.  The definitive 
diagnosis was Hodgkin Lymphoma with cutaneous 
involvement.
 She received eight cycles of treatment consisting 
of Chlorambucil, Vinblastine, Procarbazine, 
Prednisolone alternating with Adriamycin, Bleomycin, 
Vincristine and Dacarbazine (UKCCSG Hodgkins 
2000 Protocol). The skin lesions cleared completely 
by the fouth cycle. Follow up investigations including 
ultrasound scans and Chest Xrays have remained 
normal and she is clinically disease free three years 
after first presentation. 
DISCUSSION
Hodgkin lymphoma, when it presents as systemic 
disease and in advanced stages can infiltrate multiple 
lymph node sites, spleen and bone marrow. Non-
specific cutaneous manifestations of the disease 
are not uncommon and some authors have put 
the prevalence between 13-50% (4,7). These lesions 
include; pruritis and associated prurigo, acquired 
ichthyosis, Addison-like hyperpigmentation, herpes 
zoster and alopecia (7).
 Specific cutaneous disease, which is rare, was 
first described by Grotz in 1906 (5) and in reports 
occurred in 0.5 – 7.5% of Hodgkin lymphoma (1,3,5). 
It is thought that the incidence has declined with the 
advent of multimodal therapy and stem cell transplant 
for Hodgkin lymphoma (1,7). On literature review, it 
has never been reported in a child younger than 19 
years of age (8,9).
 The characteristic lesions are usually painless 
erythematous papules and nodules that frequently 
ulcerate. Three mechanisms have been proposed 
as the possible mode of spread; haematogenous 
dissemination, lymphatic spread or retrograde 
direct extension from affected lymph nodes to the 
skin (1,2,7,10). It is believed that retrograde direct 
extension is the most common mode of spread as 
the lesions commonly appear over areas drained by 
tumour-positive lymph nodes (4,7). This appears to 
be the mechanism of spread with this patient who 
had axillary and cervical nodes associated with the 
lesions on the chest and arm. Involvement of the 
trunk is considered to be the most frequent site (1,5).
 The majority of reported cases occurred in 
patients with Nodular Sclerosing Type of Hodgkin 
Lymphoma (1, 10) as in this case. The results of 
immune-histo-chemistry using peroxidase technique 
were in keeping with findings reported in literature 
with CD30 positivity, CD45 negativity and CD3 
negativity. CD15 negativity may be observed in 
cutaneous infiltrates (10).  
 This patient has remained disease free two and 
a half years post treatment completion contrary to 
reports of poor outcomes associated with most cases 
in the adult population (1,3,5). There have been some 
reported cases of good response to treatment (11). 
 This case emphasises the importance of precise 
pathological diagnoses of lesions, even in resource 
limited settings, to ensure appropriate treatment. 
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